GRAIL, Inc.

GRAL

GRAIL, Inc.

GRAL

Insider Sentiment (TTM):

Last Purchase:2024-10-09Last Sale:2026-06-04Shares Purchased (TTM):0Shares Sold (TTM):1,493,560

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:34,790,857Shares Outstanding:40,640,879Institutional Ownership Pct.:85.61%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Assets
Assets Current
Nonrelated Party	-	-	-	-	-	-	-	2	13
Cash And Cash Equivalents At Carrying Value	56	69	250	127	127	134	214	854	959
Debt Securities Available For Sale Excluding Accru…	806	754	655	413	475	541	549	-	-
Accounts Receivable Net Current	20	20	18	16	16	19	20	-	-
Supplies	18	17	16	18	20	19	19	-	-
Prepaid Expense And Other Assets Current	16	17	15	15	13	15	17	-	-
Assets Current	915	877	954	589	652	728	820	910	1,019
Property Plant And Equipment Net	44	48	52	56	60	65	69	-	-
Operating Lease Right Of Use Asset	45	48	52	56	60	62	66	71	75
Restricted Cash Noncurrent	7	7	7	7	3	3	3	4	4
Intangible Assets Net Excluding Goodwill	1,781	1,816	1,851	1,885	1,920	1,982	2,017	2,051	2,086
Other Assets Noncurrent	7	7	7	7	7	7	8	8	8
Goodwill	-	-	-	-	-	-	0	0	0
Assets	2,844	2,803	2,922	2,601	2,703	2,848	2,983	3,118	3,270
Accrued Liabilities Current	-	-	-	-	-	-	-	-	57
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	7	5	2	3	6	6	5	-	-
Accrued Liabilities Current And Noncurrent	64	58	64	58	49	54	57	-	-
Operating Lease Liability Current	45	10	12	14	14	13	13	14	14
Other Liabilities Current	1	2	2	2	2	3	2	2	1
Deferred Compensation Liability Current	-	-	-	-	-	-	0	0	0
Liabilities Current	84	75	80	77	71	75	77	94	88
Operating Lease Liability Noncurrent	81	41	43	45	48	51	55	59	62
Deferred Income Tax Liabilities Net	134	184	219	236	266	305	346	375	422
Other Liabilities Noncurrent	3	3	3	3	3	2	2	2	2
Liabilities	301	303	344	361	388	434	480	530	575
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	12,956	12,804	12,787	12,350	12,336	12,322	12,305	12,292	12,274
Accumulated Other Comprehensive Income Loss Net Of…	2	2	3	2	2	2	1	2	1
Retained Earnings Accumulated Deficit	-10,415	-10,305	-10,212	-10,113	-10,024	-9,910	-9,803	-9,706	-9,581
Members Capital	-	-	-	-	-	-	0	-	0
Stockholders Equity	2,543	2,501	2,578	2,240	2,315	2,414	2,503	2,588	2,695
Liabilities And Stockholders Equity	2,844	2,803	2,922	2,601	2,703	2,848	2,983	3,118	3,270
Related Party	-	-	0	-0	-0	0	0	2	13
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	50	-
Members Equity	-	-	-	-	-	-	2,503	-	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-
Common Stock Shares Authorized	1,500	1,500	1,500	1,500	1,500	1,500	1,500	1,500	-
Common Stock Shares Issued	45	41	40	36	36	35	34	33	0
Shares Outstanding	45	41	-	36	36	35	34	33	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	13.92%	4.77%	7.82%	-	-	-	-	-	-	-	-	-
2025	16.63%	42.05%	-0.30%	8.62%	92.89%	170.54%	21.37%	6.81%	17.57%	24.02%	21.92%	61.66%
2024	-	-	-	-19.89%	-17.74%	-14.46%	35.80%	22.17%	90.20%	-29.69%	-2.87%	4.91%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Liquidity Ratios
Current Ratio	10.95	11.74	11.97	7.61	9.23	9.71	10.66	9.65	11.55
Quick Ratio	10.76	11.52	11.78	7.42	9.04	9.50	10.43	9.65	11.55
Working Capital	831.18M	802.64M	874.18M	511.95M	581.21M	652.68M	742.94M	815.43M	930.50M
Leverage & Debt
Debt to Equity	0.12	0.12	0.13	0.16	0.17	0.18	0.19	0.20	0.21
Debt Ratio	0.11	0.11	0.12	0.14	0.14	0.15	0.16	0.17	0.18
Efficiency & Turnover
Asset Turnover TTM	0.06	0.06	0.05	0.06	0.05	0.06	-	-	-
Days Sales Outstanding TTM	39.83	46.35	47.87	35.26	36.98	44.77	-	-	-
Receivables Turnover TTM	9.16	7.87	7.62	10.35	9.87	8.15	-	-	-
Per Share Metrics
Diluted EPS TTM	-9.08	-9.73	-11.11	-17.31	-18.49	-62.18	-	-	-
Free Cash Flow Per Share TTM	-7.05	-7.19	-8.16	-6.50	-7.73	-19.75	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Margin Metrics
Gross Profit Margin TTM	-	50.44%	50.23%	50.22%	47.85%	48.93%	-	-	-
Operating Profit Margin TTM	-338.40%	-348.66%	-381.98%	-475.90%	-534.35%	-1,488.11%	-	-	-
Net Profit Margin TTM	-236.95%	-253.22%	-277.47%	-370.91%	-411.08%	-1,355.01%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	2.64%	-0.83%	-	-	-	-	-	-	-
Net Income Growth (1Y)	-40.84%	-81.47%	-	-	-	-	-	-	-
EPS Growth (1Y)	-50.88%	-84.36%	-	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-7.52	-5.31	-7.70	-3.42	-2.78	-0.41	-	-	-
P/B TTM	1.16	0.84	1.22	0.95	0.80	0.36	0.23	0.17	0.18
P/S TTM	17.81	13.45	21.37	12.67	11.43	5.57	-	-	-
Market Cap	2.94B	2.10B	3.15B	2.14B	1.84B	876.24M	569.44M	438.67M	477.23M
Enterprise Value	2.88B	2.02B	2.89B	2.00B	1.71B	738.99M	351.85M	-418.80M	-481.62M
Calculated Values
Free Cash Flow TTM	-303.89M	-292.33M	-299.92M	-234.76M	-276.68M	-677.44M	-	-	-
Net Debt	-62.62M	-76.32M	-256.70M	-133.87M	-130.78M	-137.24M	-217.58M	-857.47M	-958.85M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-04Sale

Owner: Partridge, Andrew John

Title: Chief Growth Officer

Shares: 1,491

Price/Share: $61.08

Value: $91,070.28

Shares Owned: 163,738

Relationship: Officer

Ownership: Direct

2026-04-08Sale

Owner: Freidin, Aaron

Title: Chief Financial Officer

Shares: 45,806

Price/Share: $49.92

Value: $2,286,635.52

Shares Owned: 260,669

Relationship: Officer

Ownership: Direct

2026-04-08Sale

Owner: Ofman, Joshua J.

Title: President

Shares: 61,665

Price/Share: $49.92

Value: $3,078,316.80

Shares Owned: 371,216

Relationship: Director,Officer

Ownership: Direct

2026-04-08Sale

Owner: Ragusa, Robert P

Title: Chief Executive Officer

Shares: 123,502

Price/Share: $49.92

Value: $6,165,219.84

Shares Owned: 518,582

Relationship: Director,Officer

Ownership: Direct

2026-03-09Sale

Owner: Ofman, Joshua J.

Title: President

Shares: 2,937

Price/Share: $47.34

Value: $139,037.58

Shares Owned: 432,881

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-04	Partridge, Andrew John	Officer	Chief Growth Officer	Direct	Sale	1,491	61.08	$91,070.28	163,738	4
2026-04-08	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	45,806	49.92	$2,286,635.52	260,669	4
2026-04-08	Ofman, Joshua J.	Director,Officer	President	Direct	Sale	61,665	49.92	$3,078,316.80	371,216	4
2026-04-08	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	123,502	49.92	$6,165,219.84	518,582	4
2026-03-09	Ofman, Joshua J.	Officer	President	Direct	Sale	2,937	47.34	$139,037.58	432,881	4
2026-03-09	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	2,492	47.34	$117,971.28	306,475	4
2026-03-09	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	7,461	47.33	$353,129.13	642,084	4
2026-03-02	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	9,573	50.98	$488,031.54	309,622	4
2026-03-02	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	37,504	50.96	$1,911,203.84	650,525	4
2026-03-02	Ofman, Joshua J.	Officer	President	Direct	Sale	17,002	50.92	$865,741.84	436,508	4
2025-12-03	Ofman, Joshua J.	Officer	President	Direct	Sale	13,000	100.00	$1,300,000.00	368,818	4
2025-12-03	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	40,000	95.80	$3,832,000.00	688,029	4
2025-12-03	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	25,000	99.15	$2,478,750.00	259,077	4
2025-11-17	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	1,697	79.20	$134,402.40	284,077	4
2025-11-17	Illumina,, Inc.	TenPercentOwner	-	Direct	Sale	1,000,000	79.85	$79,850,000.00	3,502,126	4
2025-10-16	Ofman, Joshua J.	Officer	President	Direct	Sale	6,114	82.01	$501,409.14	381,818	4
2025-10-15	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	7,239	68.88	$498,622.32	727,388	4
2025-10-06	Ofman, Joshua J.	Officer	President	Direct	Sale	81,385	62.50	$5,086,562.50	396,797	4
2025-10-02	Ofman, Joshua J.	Officer	President	Direct	Sale	9,692	64.00	$620,288.00	478,182	4
2025-08-19	Ofman, Joshua J.	Officer	President	Direct	Sale	4,202	32.02	$134,548.04	487,874	4
2025-08-19	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	877	32.02	$28,081.54	285,143	4
2025-07-15	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	8,000	38.93	$311,440.00	286,020	4
2025-07-01	Ding, Chun R	TenPercentOwner	-	Indirect	Sale	339,800	49.57	$16,843,886.00	3,305,055	4
2025-06-30	Ofman, Joshua J.	Officer	President	Direct	Sale	9,692	52.00	$503,984.00	492,076	4
2025-06-12	Ofman, Joshua J.	Officer	President	Direct	Sale	9,692	42.30	$409,971.60	501,768	4
2025-05-02	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	41,150	33.93	$1,396,219.50	294,020	4
2025-05-02	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	94,035	33.93	$3,190,607.55	734,627	4
2025-05-02	Ofman, Joshua J.	Officer	President	Direct	Sale	48,213	33.93	$1,635,867.09	511,460	4
2025-03-11	Ofman, Joshua J.	Officer	President	Direct	Sale	2,109	31.20	$65,800.80	559,673	4/A
2025-03-11	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	1,816	31.20	$56,659.20	335,170	4/A
2025-03-11	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	7,625	31.21	$237,976.25	828,662	4/A
2025-03-07	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	7,625	31.21	$237,976.25	828,662	4
2025-03-07	Ofman, Joshua J.	Officer	President	Direct	Sale	2,109	31.20	$65,800.80	559,673	4
2025-03-07	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	1,816	31.20	$56,659.20	335,170	4
2025-03-05	Ofman, Joshua J.	Officer	President	Direct	Sale	525	41.51	$21,792.75	561,782	4
2025-03-05	Ragusa, Robert P	Director,Officer	Chief Executive Officer	Direct	Sale	994	41.51	$41,260.94	836,287	4
2025-03-05	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	521	41.51	$21,626.71	336,986	4
2024-11-18	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	30,452	14.02	$426,937.04	268,277	4
2024-10-15	Ragusa, Robert P	Officer	Chief Executive Officer	Direct	Sale	123,454	14.02	$1,730,825.08	612,661	4
2024-10-09	Ding, Chun R	TenPercentOwner	-	Indirect	Purchase	16,200	12.92	$209,304.00	3,644,855	4
2024-08-21	Ofman, Joshua J.	Officer	President	Direct	Sale	74,084	16.25	$1,203,865.00	191,757	4
2024-08-21	Freidin, Aaron	Officer	Chief Financial Officer	Direct	Sale	15,641	16.25	$254,166.25	173,429	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

85.61%

Inst. Shares: 34,790,857

Shares Outstanding: 40,640,879

2025-12-31

80.09%

Inst. Shares: 29,437,481

Shares Outstanding: 36,753,751

2025-09-30

67.55%

Inst. Shares: 24,401,047

Shares Outstanding: 36,124,256

2025-06-30

71.55%

Inst. Shares: 25,609,099

Shares Outstanding: 35,793,154

2025-03-31

70.48%

Inst. Shares: 24,181,708

Shares Outstanding: 34,308,435

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	34,790,857	40,640,879	85.61%
2025-12-31	29,437,481	36,753,751	80.09%
2025-09-30	24,401,047	36,124,256	67.55%
2025-06-30	25,609,099	35,793,154	71.55%
2025-03-31	24,181,708	34,308,435	70.48%
2024-12-31	25,738,051	31,901,259	80.68%
2024-09-30	19,463,891	31,880,054	61.05%
2024-06-30	20,290,532	31,049,148	65.35%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

GRAIL, Inc. (GRAL) — SEC Financial Statements & Analysis

GRAIL, Inc. (GRAL) is a services-medical laboratories company, incorporated in DE. GRAIL, Inc. trades on Nasdaq as: GRAL. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), GRAIL, Inc. reported a 2.64% year-over-year revenue growth, a Gross Profit Margin of 50.44% (TTM), a Debt-to-Equity ratio of 0.12x, a Price-to-Sales (P/S) ratio of 17.81x (TTM), a Price-to-Book (P/B) ratio of 1.16x (TTM), at a market cap of $2.94B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 2.64%
Gross Profit Margin TTM: 50.44%
Debt To Equity: 0.12x
P/S TTM: 17.81x
P/B TTM: 1.16x
Market Cap: $2.94B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is GRAIL, Inc. in?

GRAIL, Inc. (GRAL) operates in the Services-Medical Laboratories industry.

What is GRAL's market cap?

GRAIL, Inc. (GRAL) has a market capitalization of $2.94B as of 2026-06-30.

What exchange does GRAL trade on?

GRAIL, Inc. (GRAL) trades on the Nasdaq.

Where is GRAIL, Inc. incorporated?

GRAIL, Inc. is incorporated in DE.

GRAIL, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

GRAIL, Inc. (GRAL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.
Main Street's price.

GRAIL, Inc. (GRAL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.